Please wait while the formulary information is being retrieved.
TALIVA (folic acid/vit B6/vit B12/omega-3/dha/epa/beta-sitosterol)
1 mg-12.5 mg-0.5 mg-500 mg capsule
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- History of total gastrectomy
- Leber's hereditary optic atrophy
Contraindicated
- None
Severe
Moderate
- Atrophic gastritis
- Hypokalemia
TALIVA (folic acid/vit B6/vit B12/omega-3/dha/epa/beta-sitosterol)
- None
- None
More Frequent
Severe
Less Severe
- None
- Dysgeusia
- Dyspepsia
- Eructation
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Bronchospastic pulmonary disease
- Concentration difficulty
- Hemorrhage
- Increased alanine transaminase
- Increased aspartate transaminase
Less Severe
- Abdominal distension
- Abnormal hepatic function tests
- Acute confusion
- Anorexia
- Constipation
- Depression
- Dysgeusia
- Erythema
- Excitement
- Flatulence
- Irritability
- Malaise
- Nausea
- Pruritus of skin
- Skin rash
- Sleep disorder
- Urticaria
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Folic Acid
- Severity Level:
A
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool